Jpmorgan Chase & CO Biolife Solutions Inc Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Biolife Solutions Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 278,333 shares of BLFS stock, worth $7.07 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
278,333
Previous 285,735
2.59%
Holding current value
$7.07 Million
Previous $6.12 Million
13.77%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding BLFS
# of Institutions
199Shares Held
45MCall Options Held
8.2KPut Options Held
4K-
Casdin Capital, LLC New York, NY8.71MShares$221 Million16.93% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$139 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA3.2MShares$81.3 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.85MShares$72.3 Million0.0% of portfolio
-
Fred Alger Management, LLC New York, NY1.58MShares$40.1 Million0.2% of portfolio
About BIOLIFE SOLUTIONS INC
- Ticker BLFS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 42,684,400
- Market Cap $1.08B
- Description
- BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...